Neuropeptide specificity of prostaglandin E2-induced activation of splenic and renal sympathetic nerves in the rat

Brain, Behavior, and Immunity

Volumn 17, Issue 6, 2003, Pages 442-452

  MacNeil, Brian J ^a   Jansen, Arno H ^a   Greenberg, Arnold H ^b   Nance, Dwight M ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Antagonist; Arginine vasopressin; Corticotropin releasing factor; Electrophysiology; Oxytocin; Prostaglandin; Renal nerve; Splenic nerve; Sympathetic; Urocortin

Indexed keywords

ARGIPRESTOCIN; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; NEUROPEPTIDE; PROSTAGLANDIN E2; VASOPRESSIN;

ARTICLE; ATTENUATION; CONSCIOUSNESS; CONTROLLED STUDY; KIDNEY NERVE; NERVE CONDUCTION; NERVE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SPLEEN; SYMPATHETIC NERVE; SYMPATHETIC OPHTHALMIA;

EID: 0142247575     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-1591(03)00050-3     Document Type: Article

References (42)

1. Andrews T.J., Thrasivoulou C., Nesbit W., Cowen T. Target-specific differences in the dendritic morphology and neuropeptide content of neurons in the rat SCG during development and aging. J. Comp. Neurol. 368:1996;33-44.
2. Appel N.M., Elde R.P. The intermediolateral cell column of the thoracic spinal cord is comprised of target-specific subnuclei: Evidence from retrograde transport studies and immunohistochemistry. J. Neurosci. 8:1988;1767-1775.
3. Bankowski K., Manning M., Seto J., Haldar J., Sawyer W.H. Design and synthesis of potent in vivo antagonists of oxytocin. Int. J. Pept. Protein Res. 16:1980;382-391.
4. Brown M.R., Fisher L.A., Spiess J., Rivier C., Rivier J., Vale W. Corticotropin-releasing factor: Actions on the sympathetic nervous system and metabolism. Endocrinology. 111:1982;928-931.
5. Brown R., Li Z., Vriend C.Y., Nirula R., Janz L., Falk J., Nance D.M., Dyck D.G., Greenberg A.H. Suppression of splenic macrophage interleukin-1 secretion following intracerebroventricular injection of interleukin-. 1β: Evidence for pituitary-adrenal and sympathetic control Cell. Immunol. 132:1991;84-93.
6. Cechetto D.F., Saper C.B. Neurochemical organization of the hypothalamic projection to the spinal cord in the rat. J. Comp. Neurol. 272:1988;579-604.
7. Diamant M., DeWied D. Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats. Endocrinology. 129:1991;446-454.
8. Ericsson A., Arias C., Sawchenko P.E. Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1 beta. J. Neurosci. 17:1997;7166-7179.
9. Fisher L.A. Central autonomic modulation of cardiac baroreflex by corticotropin-releasing factor. Am. J. Physiol. 256:1989;H949-H955.
10. Havel P.J., Veith R.C., Dunning B.E., Taborsky G.J. Jr. Pancreatic noradrenergic nerves are activated by neuroglucopenia but not by hypotension or hypoxia in the dog. Evidence for stress-specific and regionally selective activation of the sympathetic nervous system. J. Clin. Invest. 82:1988;1538-1545.
11. Holets V., Elde R. The differential distribution and relationship of serotonergic and peptidergic fibers to sympathoadrenal neurons in the intermediolateral cell column of the rat: A combined retrograde axonal transport and immunofluorescence study. Neuroscience. 7:1982;1155-1174.
12. Hosoya Y., Matsukawa M., Okado N., Sugiura Y., Kohno K. Oxytocinergic innervation to the upper thoracic sympathetic preganglionic neurons in the rat: A light and electron microscopical study using a combined retrograde transport and immunocytochemical technique. Exp. Brain Res. 107:1995;9-16.
13. Hosoya Y., Matsushita M. Identification and distribution of the spinal and hypophysial projection neurons in the paraventricular nucleus of the rat. A light and electron microscopic study with the horseradish peroxidase method. Exp. Brain Res. 35:1979;315-331.
14. Ichijo T., Katafuchi T., Hori T. Central interleukin-1β enhances splenic sympathetic nerve activity in rats. Brain Res. Bull. 34:1994;547-553.
15. 2 in the brain on splenic sympathetic nerve activity in rats J. Auton. Nerv. Syst. 67:1997;200-206.
16. Kosoyan H.P., Wei J.Y., Tache Y. Intracisternal sauvagine is more potent than corticotropin-releasing factor to decrease gastric vagal efferent activity in rats. Peptides. 20:1999;851-858.
17. Krassioukov A.V., Gelb A.W., Weaver L.C. Action of propofol on central sympathetic mechanisms controlling blood pressure. Can. J. Anaesth. 40:1993;761-769.
18. Kurosawa M., Sato A., Swenson R.S., Takahashi Y. Sympatho-medullary functions in response to intracerebroventricularly injected corticotropin- releasing factor in anesthetized rats. Brain Res. 367:1986;250-257.
19. Lacroix S., Rivest S. Functional circuitry in the brain of immune-challenged rats: Partial involvement of prostaglandins. J. Comp. Neurol. 387:1997;307-324.
20. Lacroix S., Vallieres L., Rivest S. C-fos mRNA pattern and corticotropin-releasing factor neuronal activity throughout the brain of rats injected centrally with a prostaglandin of E2 type. J. Neuroimmunol. 70:1996;163-179.
21. MacNeil B.J., Jansen A.H., Greenberg A.H., Nance D.M. Activation and selectivity of splenic sympathetic nerve electrical activity response to bacterial endotoxin. Am. J. Physiol. 270:1996;R264-R270.
22. 2 Am. J. Physiol. 278:2000;R1321-R1328.
23. MacNeil B.J., Jansen A.H., Janz L., Greenberg A.H., Nance D.M. Peripheral endotoxin increases splenic sympathetic nerve activity via central prostaglandin synthesis. Am. J. Physiol. 273:1997;R609-R614.
24. 1 -receptor) responses to vasopressin J. Med. Chem. 33:1990;3079-3086.
25. Menzaghi F., Howard R.L., Heinrichs S.C., Vale W., Rivier J., Koob G.F. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats. J. Pharmacol. Exp. Ther. 269:1994;564-572.
26. Nakamori T., Morimoto A., Murakami N. Effect of a central CRF antagonist on cardiovascular and thermoregulatory responses induced by stress or IL-1β Am. J. Physiol. 265:1993;R834-R839.
27. Nance D.M., Burns J. Innervation of the spleen: Evidence for an absence of afferent innervation. Brain Behav. Immun. 3:1989;281-290.
28. Nijsen M.J., Croiset G., Diamant M., Stam R., Delsing D., de Wied D., Wiegant V.M. Conditioned fear-induced tachycardia in the rat: Vagal involvement. Eur. J. Pharmacol. 350:1998;211-222.
29. Nijsen M.J., Croiset G., Diamant M., Stam R., Kamphuis P.J., Bruijnzeel A., de Wied D., Wiegant V.M. Endogenous corticotropin-releasing hormone inhibits conditioned-fear-induced vagal activation in the rat. Eur. J. Pharmacol. 389:2000;89-98.
30. Potter E., Sutton S., Donaldson C., Chen R., Perrin M., Lewis K., Sawchenko P.E., Vale W. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc. Natl. Acad. Sci. USA. 91:1994;8777-8781.
31. Pyner S., Coote J.H. Evidence that sympathetic preganglionic neurons are arranged in target-specific columns in the thoracic spinal cord of the rat. J. Comp. Neurol. 342:1994;15-22.
32. Rivest S., Laflamme N. Neuronal activity and neuropeptide gene transcription in the brains of immune-challenged rats. J. Neuroendocrinol. 7:1995;501-525.
33. Rothwell N.J. Central activation of thermogenesis by prostaglandins: Dependence on CRF. Horm. Metab. Res. 22:1990;616-618.
34. Saper C.B., Loewy A.D., Swanson L.W., Cowan W.M. Direct hypothalamo-autonomic connections. Brain Res. 117:1976;305-312.
35. Sawchenko P.E., Swanson L.W. Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. J. Comp. Neurol. 205:1982;260-272.
36. Swanson L.W., McKellar S. The distribution of oxytocin- and neurophysin-stained fibers in the spinal cord of the rat and monkey. J. Comp. Neurol. 188:1979;87-106.
37. Tache Y., Martinez V., Million M., Wang L. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: Role of brain corticotropin-releasing factor receptors. Am. J. Physiol Gastrointest. Liver Physiol. 280:2001;G173-G177.
38. Vaccari C., Lolait S.J., Ostrowski N.L. Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain. Endocrinology. 139:1998;5015-5033.
39. Wan W., Janz L., Vriend C.Y., Sorensen C.M., Greenberg A.H., Nance D.M. Differential induction of c-fos immunoreactivity in hypothalamus and brain stem nuclei following central and peripheral administration of endotoxin. Brain Res. Bull. 32:1993;581-587.
40. Wan W., Vriend C.Y., Wetmore L., Gartner J.G., Greenberg A.H., Nance D.M. The effects of stress on splenic immune function are mediated by the splenic nerve. Brain Res. Bull. 30:1993;101-105.
41. Wan W., Wetmore L., Sorensen C.M., Greenberg A.H., Nance D.M. Neural and biochemical mediators of endotoxin and stress-induced c-fos expression in the rat brain. Brain Res. Bull. 34:1994;7-14.
42. Zalcman S., Green-Johnson J.M., Murray L., Wan W., Nance D.M., Greenberg A.H. Interleukin-2-induced enhancement of an antigen-specific IgM plaque-forming cell response is mediated by the sympathetic nervous system. J. Pharmacol. Exp. Ther. 271:1994;977-982.